| MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3 H Hirai, M Verma, S Watanabe, C Tastad, Y Asakura, A Asakura Journal of Cell Biology 191 (2), 347-365, 2010 | 224 | 2010 |
| Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice M Verma, Y Asakura, H Hirai, S Watanabe, C Tastad, GH Fong, M Ema, ... Human molecular genetics 19 (21), 4145-4159, 2010 | 65 | 2010 |
| MyoD Gene Suppression by Oct4 Is Required for Reprogramming in Myoblasts to Produce Induced Pluripotent Stem Cells S Watanabe, H Hirai, Y Asakura, C Tastad, M Verma, C Keller, JR Dutton, ... Stem cells 29 (3), 505-516, 2011 | 49 | 2011 |
| Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium Y Nakamura, Y Asakura, BA Piras, H Hirai, CT Tastad, M Verma, AJ Christ, ... PLoS One 7 (7), e41736, 2012 | 21 | 2012 |
| Chemotherapy resistance pathways identified in ovarian cancer patients treated with neoadjuvant chemotherapy using single cell RNA sequencing of matched tumor biopsies TK Starr, S Talukdar, Z Chang, J Cepela, C Tastad, M Shetty, I Schneider, ... Cancer Research 81 (13_Supplement), 1410-1410, 2021 | | 2021 |
| Defining immune infiltrate heterogeneity and its role in ovarian cancer chemotherapy resistance using single cell RNA sequencing. S Talukdar, J Cepela, Z Chang, M Shetty, Y Zhang, M Macchietto, ... CANCER RESEARCH 80 (21), 2020 | | 2020 |
| Abstract PO-013: Defining immune infiltrate heterogeneity and its role in ovarian cancer chemotherapy resistance using single cell RNA sequencing S Talukdar, J Cepela, Z Chang, M Shetty, Y Zhang, M Macchietto, ... Cancer Research 80 (21_Supplement), PO-013-PO-013, 2020 | | 2020 |
